Anika Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 23594000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b5c9f7fe-b507-4a64-8dc6-75791db23859
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-25-001486Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b5c9f7fe-b507-4a64-8dc6-75791db23859
History
- no predecessors — first report